EMPA-VISION Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for EMPA-VISION with the United States Patent and Trademark Office. The USPTO has given the EMPA-VISION trademark a serial number of 79250954. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, December 15, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPA-VISION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

[ Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; ] Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease
empa-vision

General Information

Serial Number79250954
Word MarkEMPA-VISION
Filing DateFriday, September 28, 2018
Status706 - SECTION 71 ACCEPTED
Status DateMonday, December 15, 2025
Registration Number5847814
Registration DateTuesday, September 3, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and Services[ Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; ] Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease
Pseudo MarkEMPATHIC-VISION
Description of MarkThe mark consists of the stylized wording "EMPA-VISION" in black capital letters, except for the letter "O" which consists of multiple circles in various sizes in the colors purple, blue, and red. In the center of the "O" is a red heart. The color white is used as background.
Indication of Colors claimedThe color(s) purple, blue, red and black is/are claimed as a feature of the mark.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 6, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, January 31, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, February 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 6, 2019ASSIGNED TO EXAMINER
Tuesday, February 12, 2019APPLICATION FILING RECEIPT MAILED
Saturday, February 16, 2019NON-FINAL ACTION WRITTEN
Sunday, February 17, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, February 23, 2019REFUSAL PROCESSED BY MPU
Saturday, February 23, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 16, 2019REFUSAL PROCESSED BY IB
Friday, April 19, 2019CORRECTION TRANSACTION RECEIVED FROM IB
Monday, April 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2019CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, May 15, 2019ASSIGNED TO LIE
Friday, May 24, 2019CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 12, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 28, 2019NOTIFICATION PROCESSED BY IB
Tuesday, September 3, 2019REGISTERED-PRINCIPAL REGISTER
Monday, October 21, 2019CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, December 3, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, January 2, 2020FINAL DISPOSITION PROCESSED
Thursday, January 2, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 3, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 7, 2025TEAS SECTION 71 RECEIVED
Monday, December 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 15, 2025REGISTERED-SEC.71 ACCEPTED
Monday, December 15, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

vision empa diseases chronic kidney disease medical cardiovascular scientific diabetes research field